Aclipse Therapeutics LLC ("Aclipse" or "the Company") today announced that its M102 drug development program has been ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

ATH-1105 – A next-generation, novel, orally administered, small molecule drug candidate in development for the potential treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative ...

Baldanza has largely kept a low profile aside from co-hosting a podcast on aviation since his sudden resignation in 2016. The ...

Indivior PLC the Board of Directors (the "Board") of Indivior plc ("Indivior" or the "Company") notes the publication today of a letter from Oaktree Capital Management LP ("Oaktree") to the Board of ...

The marquee fundraiser of the Women's Guild Cedars-Sinai is set to take place at the Beverly Wilshire, a Four Season Hotel in ...

The University of Ghana (UG), in collaboration with Google Research Africa and the University College of London’s (UCL) ...

Ben Baldanza, who was perhaps best known in the aviation world for helping to pioneer discount air travel at the US's Spirit Airlines, has died aged 62. An obituary has been posted on Baldanza’s ...

Neurosense Therapeutics (NASDAQ:NRSN) is developing novel treatments for neurodegenerative diseases like amyotrophic lateral ...

Former Spirit Airlines CEO and airline industry communicator Ben Baldanza passed away on November 5, 2024, at the age of 62.

"According to the latest study from BCC Research, Antibody Drugs: Technologies and Global Markets is expected to grow from $242.6 billion in 2024 to $412.1 billion ...